See below ACCISS reports on insulin prices in low-and middle- income countries published in 2016 and 2019.
In 2016, insulin price and availability surveys in three sectors were undertaken in 15 low-and middle-income countries.
This article highlights how price components on insulins can help design interventions to improve insulin affordability in LMICs.
This profile analyses government procurement prices for insulin, patient prices and affordability of insulin in the public and private sectors, and insulin reimbursement prices. A time-series analysis of insulin prices listed in Management Sciences for Health International Drug Price Indicator Guide is also provided.
This profile describes import tariffs on retail insulin and bulk insulin over time, and identifies countries that continue to apply high tariff levels. It also identifies countries that apply value-added tax on insulin.